There are experimental records and clinical observations showing that exposure to sub-infective doses of some pathogens can result in enhanced immunity to infection when exposed to an infective dose of the same pathogen later. In vitro studies show that T-cell immunity can be a key role player in this process and antibody production may be minimal or absent.
What is known about the acquired resistance to COVID-19 in people who are exposed to repeated sub-infective doses?